Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

153 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
BRD4 inhibition sensitizes diffuse large B-cell lymphoma cells to ferroptosis.
Schmitt A, Grimm M, Kreienkamp N, Junge H, Labisch J, Schuhknecht L, Schönfeld C, Görsch E, Tibello A, Menck K, Bleckmann A, Lengerke C, Rosenbauer F, Grau M, Zampieri M, Schulze-Osthoff K, Klener P, Dolnikova A, Lenz G, Hailfinger S. Schmitt A, et al. Among authors: bleckmann a. Blood. 2023 Sep 28;142(13):1143-1155. doi: 10.1182/blood.2022019274. Blood. 2023. PMID: 37294920
Liquid Biopsies in Lung Cancer.
Kemper M, Krekeler C, Menck K, Lenz G, Evers G, Schulze AB, Bleckmann A. Kemper M, et al. Among authors: bleckmann a. Cancers (Basel). 2023 Feb 23;15(5):1430. doi: 10.3390/cancers15051430. Cancers (Basel). 2023. PMID: 36900221 Free PMC article. Review.
Complete Metabolic Response to Combined Immune Checkpoint Inhibition after Progression of Metastatic Colorectal Cancer on Pembrolizumab: A Case Report.
Krekeler C, Wethmar K, Mikesch JH, Kerkhoff A, Menck K, Lenz G, Schildhaus HU, Wessolly M, Hoffmann MW, Pascher A, Asmus I, Wardelmann E, Bleckmann A. Krekeler C, et al. Among authors: bleckmann a. Int J Mol Sci. 2023 Jul 27;24(15):12056. doi: 10.3390/ijms241512056. Int J Mol Sci. 2023. PMID: 37569431 Free PMC article.
[No title available]
[No authors listed] [No authors listed] PMID: 38193714
Radiomics of Tumor Heterogeneity in 18F-FDG-PET-CT for Predicting Response to Immune Checkpoint Inhibition in Therapy-Naïve Patients with Advanced Non-Small-Cell Lung Cancer.
Ventura D, Schindler P, Masthoff M, Görlich D, Dittmann M, Heindel W, Schäfers M, Lenz G, Wardelmann E, Mohr M, Kies P, Bleckmann A, Roll W, Evers G. Ventura D, et al. Among authors: bleckmann a. Cancers (Basel). 2023 Apr 14;15(8):2297. doi: 10.3390/cancers15082297. Cancers (Basel). 2023. PMID: 37190228 Free PMC article.
153 results